Timely overview of important topic by @ritahamad.bsky.social #HAScholar @Health_Affairs. Social Policies as Determinants of Health: New Evidence, Ongoing Challenges, and Future Pathways url: academic.oup.com/healthaffair...
Social Policies as Determinants of Health: New Evidence, Ongoing Challenges, and Future Pathways
Abstract. Despite acknowledgment that social and economic policies fundamentally shape health, persistent geographic and sociodemographic inequities in the
academic.oup.com
2 leading experts on scientific publication & former Editors-in-Chief @JAMA published commentary in #HAScholar @Health_Affairs on Administration's focus on “gold standard science” – its opportunities but also its challenges. academic.oup.com/healthaffair...
Validate User
academic.oup.com
Drummond was great mentor to me...continuing his efforts now! Commentary from 2 experts on scientific publication & former Editors-in-Chief @JAMA in #HAScholar @Health_Affairs on Administration's focus on “gold standard science” – opportunities but also challenges. academic.oup.com/healthaffair...
M.I.T. Rejects a White House Offer for Special Funding Treatment www.nytimes.com/2025/10/10/u...
M.I.T. Rejects a White House Offer for Special Funding Treatment
www.nytimes.com
Thrilled to publish this in #HAScholar @ Health Affairs. "So much is changing in the drug approval and pricing space, and in order to ensure affordability for patients and society,
policymakers should pay close attention to the merits of a U.S.-based value assessment approach
policymakers should pay close attention to the merits of a U.S.-based value assessment approach
Useful! Provenance and Funding of Extremely Cited Biomedical Articles Published Between 2003 and 2024 url: jamanetwork.com/journals/jam...
Provenance and Funding of Extremely Cited Biomedical Articles Published Between 2003 and 2024
This cross-sectional study explores the origin and funding of top-cited biomedical publications with regard to numbers of articles originating in the US and supported by the National Institutes of Hea...
jamanetwork.com
Health and Medical Research Funding in a Divided America — How to Increase Support | New England Journal of Medicine www.nejm.org/doi/full/10....
Health and Medical Research Funding in a Divided America — How to Increase Support | NEJM
A majority of U.S. Republicans support withholding federal funding from “ultraliberal” universities — but maintaining medical research funding. A national campaign could boost advocacy for such a c...
www.nejm.org
Join us on October 28 for a hybrid public workshop to discuss how AI is impacting translational #genomics research and genomics clinical care.
Register here: ow.ly/GC1x50WQlHm
#GenomicsRT
Register here: ow.ly/GC1x50WQlHm
#GenomicsRT
Exploring Applications of AI in Genomics and Precision Health: A Workshop
Register for this event from the National Academies of Sciences, Engineering, and Medicine.
ow.ly
Reposted by Kathryn A. Phillips
How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9
How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patients
Abstract. The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestin
tinyurl.com
Many questions about Pfizer deal with Trump Administration to avoid tariffs. Why does the federal government need to become a drug marketer? Doesn’t it already do enough not very well? www.wsj.com/opinion/dona... via @WSJopinion
Opinion | America’s Pharmacist in Chief
The President becomes a drug marketer, while Pfizer gets a tariff break.
www.wsj.com
"The world of scientific research still needs a Drummond Rennie." Remembering Drummond Rennie—Champion of Integrity in Science and Scientific Publication jamanetwork.com/journals/jam...
Remembering Drummond Rennie—Champion of Integrity in Science and Scientific Publication
Drummond Rennie, physician, scientist, editor, climber, tireless promoter of integrity and transparency in science, and mentor to many, died on September 12, 2025, at the age of 89.
jamanetwork.com
Here's where behavioral economics and the great insights of Daniel Kahneman (who I learned so much from when I took his class at UC-Berkeley) could be useful....
Nicely nuanced discussion about balancing risk/benefit. This struck me “COVID vaccine decision is qualitatively different than vaccines such as polio... because the vaccines prevent transmission. With COVID vaccination, the benefit is to the individual, with modest effects on transmission.”
Good description of nuances after court decision on LDTs: "leaves laboratories to trek through the middle, a Sahara-sized space complete with shifting, if metaphorical, sands." www.captodaymag.com/captoday/lib...
CAP TODAY - Where court’s LDT decision leaves labs
The Food and Drug Administration’s efforts to regulate laboratory-developed tests as medical devices came to a decisive halt this spring.
www.captodaymag.com
On the rare day that it's 85 degrees in San Francisco, one must eat soft serve on the Bay!
by Robert M. Califf — Reposted by Kathryn A. Phillips
An opinion about the need to better understand the framing and decision making that impacts so much of preventive public health--"habits" and inconveniences to prevent low probability, but high impact future events in return for some up front risk.
substack.com/@robcaliff27...
substack.com/@robcaliff27...
Interventions for Low-Probability Events
Recently, I have been struggling to understand why so few people have taken the updated COVID booster when the benefit-risk calculation seems so straightforward.
substack.com
Details on demands by Trump Administration to UCLA that could have far-reaching and long-lasting implications for entire UC system. dailybruin.com/2025/09/15/t...
Trump administration makes demands for UCLA policy changes in exchange for funding - Daily Bruin
The Trump administration is seeking to exert control over several of UCLA’s admissions, protest and health care policies in exchange for the university’s research funding, according to a draft settlem...
dailybruin.com
Interesting book about my alma mater @UCBerkeley's evolution from early backlash against corporate collaborations to current exuberance for entrepreneurs and startups. iande.berkeley.edu/startupcampus
Startup Campus: How UC Berkeley Became an Unexpected Leader in Entrepreneurship and Startups | Innovation & Entrepreneurship
iande.berkeley.edu
Sorry to hear that Drummond Rennie passed away. When he was @JAMA_current Deputy Editor based in SF, I benefited so much from his mentorship. He did not mince words in telling me when my work needed improvement - and indeed, he was right.
Several of my esteemed colleagues eg @robcaliff.bsky.social quoted re why approach creates more problems than solves. Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs kffhealthnews.org/MjA4NzEzMg via @kffhealthnews
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs - KFF Health News
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
kffhealthnews.org
Judge rules Trump administration cannot withhold funding from Harvard
www.washingtonpost.com/education/20...
www.washingtonpost.com/education/20...
Judge rules Trump administration cannot withhold funding from Harvard
The Trump administration illegally withheld federal funding for alleged antisemitism violations, a federal judge in Boston ruled.
www.washingtonpost.com
And we don't need covid-19 vaccines?! WHO now reports > 7Million deaths from the virus. data.who.int/dashboards/c...
COVID-19 deaths | WHO COVID-19 dashboard
The latest data for coronavirus (COVID-19) deaths from the WHO COVID-19 dashboard.
data.who.int